This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinates of Health
        • Disparities: Social Determinates of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinates of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASCO GU 2023
      • EAU 2023
      • SES AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer
  5. Conferences

AUA 2014

Recent Abstracts
#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Slide Presentation June 26, 2014
#AUA14 - AUA Guideline: Medical management of kidney stones - Slide Presentation May 28, 2014
#AUA14 - Poster: Retrospective evaluation of efficacy and safety of Argus sling for treatment of male stress urinary incontinence: The Canadian experience May 27, 2014
#AUA14 - Poster: Stress urinary incontinence outcomes following transvaginal sling incision May 27, 2014
#AUA14 - Poster: Sexual dysfunction and dyspareunia in the setting of vaginal mesh exposure May 27, 2014
#AUA14 - Poster: Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection May 27, 2014
#AUA14 - AUA Guideline: Diagnosis and treatment of overactive bladder (non-neurogenic) May 27, 2014
#AUA14 - Poster: Multicenter validation study of a tissue epigenenic assay to predict histopathologically cancer-negative repeat prostate biopsies May 27, 2014
#AUA14 - Poster: Overactive bladder patients ≥ 65 years of age have a similar efficacy and safety profile with onabotulinumtoxinA as patients less than 65 years of age May 27, 2014
#AUA14 - Poster: Long-term efficacy and safety of repeat onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: Third interim analysis, median 2.4 years follow-up May 27, 2014
#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection May 27, 2014
#AUA14 - Poster: Prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with prostatectomy May 27, 2014
#AUA14 - Poster: Validation of a 46-gene cell cycle progression (CCP) RNA signature for predicting prostate cancer death in a conservatively managed watchful waiting needle biopsy cohort May 27, 2014
#AUA14 - Poster: Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7 May 27, 2014
#AUA14 - Poster: Anticholinergic cycling and treatment outcomes in overactive bladder patients with urinary incontinence May 27, 2014
#AUA14 - Impact of female stress urinary incontinence surgery on pre-op overactive bladder symptoms - Session Highlights May 22, 2014
#AUA14 - Poster: Treatment practice patterns in metastatic castration-resistant prostate cancer patients prior to receiving sipuleucel-T: Data from PROCEED May 21, 2014
#AUA14 - Poster: Further characterization of the effects of prior or no prior docetaxel therapy on CRPC patients with bone metastases receiving Ra-223 in the phase 3 ALSYMPCA trial May 21, 2014
#AUA14 - Poster: Impact of prior endocrine therapy on clinical benefit of abiraterone acetate in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 May 21, 2014
#AUA14 - Poster: An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post chemotherapy May 21, 2014
Page 1 of 9
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free